Home treatment and reimbursement in The Netherlands.

Int J Antimicrob Agents

Medical Department of the Dutch Health Insurance Council, P.O. Box 396, 1196 BD, Amstelveen, Netherlands.

Published: January 1995

In The Netherlands home care is one of the most rapidly growing fields in health. It is thought to provide a cheaper alternative to hospitalization and improved quality of life for the patient. However, there is evidence that home care may result in better care but does not reduce the burden on hospital services. Studies have shown that outpatient parenteral antibiotic therapy (OPAT) is more cost-effective, resulting in an improved quality of life. The new home-treatment technology requires careful evaluation, under set guidelines, to ensure safety and effectiveness.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0924-8579(94)00055-yDOI Listing

Publication Analysis

Top Keywords

improved quality
8
quality life
8
treatment reimbursement
4
reimbursement netherlands
4
netherlands netherlands
4
netherlands care
4
care rapidly
4
rapidly growing
4
growing fields
4
fields health
4

Similar Publications

Study DesignNarrative Review.ObjectivesTo summarize the work of the AO Spine Knowledge Forum Tumor, specifically studies from the Epidemiology, Process and Outcomes in Spine Oncology (EPOSO) study.MethodsA narrative review of all published manuscripts from the EPOSO study was undertaken.

View Article and Find Full Text PDF

Mirror Therapy in Unilateral Amputee Patients With Phantom Limb Pain.

Pain Manag Nurs

March 2025

Department of Angiology and Vascular Surgery Department, Clínic Barcelona, Barcelona, Spain. Electronic address:

Unlabelled: Up to 90% of amputee patients have phantom limb pain (PLP), which is difficult to treat. The aim of this study was to assess the medium and long-term efficacy of mirror therapy (MT) in unilateral amputee adults with PLP.

Methods: We carried out an uncontrolled prospective longitudinal study.

View Article and Find Full Text PDF

Fruit, vegetables and discretionary food intake in Australian adults: Past trends and predicted progress towards population preventive health targets for 2030.

Aust N Z J Public Health

February 2025

Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health & Biosecurity, Adelaide, South Australia 5000, Australia. Electronic address:

Objective: In Australia, 'improving access to and the consumption of a healthy diet' is a focus in the National Preventive Health Strategy. The objective of this paper is to describe the past trends and future projections of population intakes against the Strategy's targets of increasing fruit consumption to 2 servings per day; increasing vegetables to 5 servings; and reducing discretionary foods to <20% of total energy by 2030.

Methods: Self-reported intake data were available from an online survey of 275,170 Australian adults collected between 2015 and 2023.

View Article and Find Full Text PDF

Background: Ventilator-associated pneumonia (VAP) is a frequent and severe complication among newborns in neonatal intensive care units (NICUs). It is associated with elevated morbidity and mortality rates, more extended hospital stays and increased health care costs. Implementing preventive care bundles and structured sets of evidence-based practices reduces VAP incidence.

View Article and Find Full Text PDF

CAR assembly line: Taking CAR T-cell manufacturing to the next level.

Best Pract Res Clin Haematol

December 2024

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

The widespread adoption of chimeric antigen receptor (CAR) T-cell therapy has been limited by complex, resource-intensive manufacturing processes. This review discusses the latest innovations aiming to improve and streamline CAR T-cell production across key steps like T-cell activation, genetic modification, expansion, and scaling. Promising techniques highlighted include generating CAR T cells from non-activated lymphocytes to retain a stem-like phenotype and function, non-viral gene transfer leveraging platforms like transposon and CRISPR, all-in-one fully automated bioreactors like the CliniMACS Prodigy and the Lonza Cocoon, rapid CAR T-cell manufacturing via abbreviating or eliminating ex vivo T-cell culture, implementing decentralized point-of-care automated manufacturing platforms, and optimizing centralized bioreactor infrastructure integrating end-to-end automation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!